Oct 25, 2018
Expiration Dates for Certain Lots of Generic Adrenaclick® Epinephrine Injection, USP Auto-Injector Extended to 20 Months
May 07, 2018
ANI Pharmaceuticals Completes Acquisition of Generic Products and Assets from Amneal/Impax
Apr 27, 2018
Amneal And Impax Receive FTC Clearance For Business Combination
Apr 27, 2018
ANI Pharmaceuticals Signs Definitive Agreements to Acquire Generic Products and Assets from Amneal/Impax
Apr 06, 2018
Impax Launches a Generic Version of Estrace® Cream (estradiol vaginal cream, USP, 0.01%)
Mar 29, 2018
Technical Perspectives on Drug Makers Stocks -- Impax Labs, Merck, Novartis, and Pfizer
Mar 27, 2018
Impax Shareholders Approve Proposed Business Combination with Amneal
Mar 07, 2018
Amneal Pharmaceuticals and Impax Laboratories to Present at the Barclays Global Healthcare Conference
Mar 01, 2018
Impax Reports Fourth Quarter and Full Year 2017 Results
Feb 20, 2018
Impax Announces the Launch of an Authorized Generic Version of Solodyn® (Minocycline HCl) Extended-Release Tablets
Jan 16, 2018
Impax to Report Fourth Quarter and Full Year 2017 Results on March 1, 2018
Jan 03, 2018
Amneal Pharmaceuticals and Impax Laboratories to Present at the 36th Annual J.P. Morgan Healthcare Conference
Dec 29, 2017
Quotidian Technical Highlights on Selected Drug Makers Stocks -- TherapeuticsMD, Impax Laboratories, GlaxoSmithKline, and AstraZeneca
Dec 19, 2017
Impax Announces Sale of Taiwan Manufacturing Facility
Dec 08, 2017
Impax Receives Tentative FDA Approval of Generic Coreg CR® (Carvedilol Phosphate) Extended-Release Capsules
Nov 09, 2017
Impax Reports Third Quarter 2017 Results
Nov 08, 2017
Impax Laboratories Mourns the Passing of Board Member Richard A. Bierly
Nov 06, 2017
Impax Announces Successful Completion of Consent Solicitation with Respect to its 2.00% Convertible Senior Notes due 2022
Oct 30, 2017
Impax Announces Consent Solicitation
Oct 23, 2017
Impax Announces FDA Approval and Launch of Generic Renvela® (Sevelamer Carbonate) Tablets, 800 mg